Výsledky vyhledávání

Editorial & Opinion

Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts.

Autor: Sánchez-Muñoz E; Servicio de Cardiología, Complejo Asistencial Universitario de León, León, Spain; Atherothrombosis Research Unit, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, Nueva York, Estados Unidos. Electronic address: enricsan2@hotmail.com., Requena-Ibáñez JA; Atherothrombosis Research Unit, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, Nueva York, Estados Unidos., Badimón JJ; Atherothrombosis Research Unit, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, Nueva York, Estados Unidos.

Publikováno v: Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2024 Jul; Vol. 77 (7), pp. 510-514. Date of Electronic Publication: 2024 Mar 22.

Zobrazit plný text záznamu

Akademický článek

High-density lipoprotein cholesterol: a new marker in heart failure.

Autor: Santos-Gallego CG; Atherothrombosis Research Unit, Cardiology Department, Mount Sinai Hospital, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, United States. Electronic address: Carlos.santos-gallego@mssm.edu., Requena-Ibáñez JA; Atherothrombosis Research Unit, Cardiology Department, Mount Sinai Hospital, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, United States., Badimón JJ; Atherothrombosis Research Unit, Cardiology Department, Mount Sinai Hospital, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, United States.

Publikováno v: Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2022 Nov; Vol. 75 (11), pp. 855-857. Date of Electronic Publication: 2022 Jul 03.

Zobrazit plný text záznamu

Akademický článek

SGLT2i in heart failure: can their benefits be expanded across the entire spectrum of ejection fraction?

Autor: Requena-Ibáñez JA; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York City, United States. Electronic address: Juan.Badimon@mssm.edu., Santos-Gallego CG; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York City, United States., Badimón JJ; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York City, United States.

Publikováno v: Revista espanola de cardiologia (English ed.) [Rev Esp Cardiol (Engl Ed)] 2022 Oct; Vol. 75 (10), pp. 833-841. Date of Electronic Publication: 2022 Jul 08.

Zobrazit plný text záznamu

Akademický článek

Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial.

Autor: Requena-Ibáñez JA; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: juan.antonio.requena.ib@gmail.com., Santos-Gallego CG; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Rodriguez-Cordero A; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Vargas-Delgado AP; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Badimón JJ; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Publikováno v: Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2022 Feb; Vol. 16 (2), pp. 102417. Date of Electronic Publication: 2022 Jan 24.

Zobrazit plný text záznamu

Plaque Rupture, Thrombosis, and Therapeutic Implications

Autor: Valentin Fuster, Badimón Jj, James H. Chesebro, John T. Fallon

Publikováno v: Pathophysiology of Haemostasis and Thrombosis. 26:269-284

The basic mechanisms of atherosclerotic progression leading to the acute coronary syndromes (ACS) have been elucidated during the few years. In this brief presentation, we outline 1) Definition of Atherosclerotic Lesions: eight morphologically differ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62eeef5e2af021ad5cbac5c7c48cfc03
https://doi.org/10.1159/000217308

Zobrazit plný text záznamu

Akademický článek

LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Autor: Sabatel-Pérez F; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiology Deparment, Complejo Hospitalario de Toledo, Toledo, Spain., García-Ropero A; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Santos-Gallego CG; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Urooj Zafar M; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Badimón JJ; Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Juan.Badimon@mssm.edu.

Publikováno v: Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2019 May; Vol. 55 (5), pp. 329-344.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání